Paracetamol (acetaminophen)

Research records

Historical source snapshot. Not freshly verified, not a recommendation. Study findings, community accounts and app defaults are not interchangeable.

Publication suitability · 2026-10-15: Historical reference only; not a clinical verification. Clinical, regulatory, efficacy, safety and dose claims are not independently established by this review.

Paracetamol (acetaminophen)

Analgesic and antipyretic, not an anti-inflammatory. The usual choice when you want pain or fever relief without suppressing inflammation.

Evidence category: Regulator / guideline. This describes the source category, not approval or certainty.

Regulatory statement in source: FDA-approved.

Paracetamol (acetaminophen) has an FDA-approved label; the linked one covers the intravenous form for mild to moderate pain, for moderate to severe pain alongside opioids, and for fever. The label carries a boxed warning about dosing errors and about acute liver failure, mostly when more than the recommended maximum is taken or when several paracetamol-containing products are combined. A 2026 review of cancer pain says the evidence for paracetamol there is limited and of low quality, with little added benefit next to strong opioids. Nothing in these links supports a specific rate of liver injury at normal use.

Benefits reported in the imported source

• Mild to moderate pain, for severe pain alongside opioids, and for fever.

Risks and limits

• Boxed warning for dosing errors and acute liver failure, mainly past the label maximum.
• Combining several paracetamol-containing products is a named cause of that liver injury.
• In cancer pain the evidence is limited and low quality, adding little next to strong opioids.

Source bottom line: Paracetamol is an approved painkiller and fever medicine whose main danger is liver failure past the label maximum.

Uncertainty: Reference information only. Not medical advice.

Study protocols — reports, not instructions

No study protocol recorded in this snapshot. This does not establish that no study exists.

Community and practice descriptions

Accounts of a practice are not evidence of safety or effectiveness. Words such as “standard”, “safe” or “recommended” describe the source account, not verified consensus or this wiki’s advice. Commercial and self-published citations are retained for traceability, not vendor endorsement or independent clinical corroboration.

Pharmacokinetic context

Historical half-life estimate: 2 hours. FDA label; 1.25-3 h Population/route context and estimates may differ. This is not a schedule or a verified human dosing rule.

Source references

• Acetaminophen Injection FDA label
• Paracetamol and NSAIDs in Cancer Pain Management: Evidence Review and Treatment Considerations (availability check 2026-10-15: possible access barrier; not independently inspected; HTTP 200)
• DailyMed: acetaminophen
• EMA: paracetamol (availability check 2026-10-15: source not retrieved; HTTP 404)